Recent developments and future directions in Guillain-Barré syndrome

Guillain‐Barré syndrome (GBS) encompasses a spectrum of acquired neuropathic conditions characterized by inflammatory demyelinating or axonal peripheral neuropathy with acute onset. Clinical and experimental studies in the past years have led to substantial progress in epidemiology, pathogenesis of...

Full description

Saved in:
Bibliographic Details
Published inJournal of the peripheral nervous system Vol. 17; no. s3; pp. 57 - 70
Main Authors Lehmann, Helmar C., Hughes, Richard A. C., Kieseier, Bernd C., Hartung, Hans-Peter
Format Journal Article
LanguageEnglish
Published Malden, USA Wiley Periodicals, Inc 01.12.2012
Wiley Subscription Services, Inc
Subjects
Animals
axonal
Demyelination
Epidemiology
experimental autoimmune neuritis
Guillain-Barre Syndrome
Guillain-Barré syndrome
Humans
immunology
Inflammation
IVIg
Peripheral neuropathy
plasma exchange
Reviews
vaccination
Online AccessGet full text

Cover

More Information
Summary:Guillain‐Barré syndrome (GBS) encompasses a spectrum of acquired neuropathic conditions characterized by inflammatory demyelinating or axonal peripheral neuropathy with acute onset. Clinical and experimental studies in the past years have led to substantial progress in epidemiology, pathogenesis of GBS variants, and identification of prognostic factors relevant to treatment. In this review we provide an overview and critical assessment of the most recent developments and future directions in GBS research.
Bibliography:ArticleID:JNS5433
ark:/67375/WNG-CHKW9WW3-G
Else Kröner- Fresenius Foundation
GBS/CIDP Foundation International
istex:5DF05AA448B0531E615469859095B45FFA1187AA
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Review-3
ISSN:1085-9489
1529-8027
1529-8027
DOI:10.1111/j.1529-8027.2012.00433.x